Skip to content

Evaluation of Antioxidants in Burn patient

Evaluation of Antioxidants as Adjuvant therapy after severe Burn: A Randomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074623
Enrollment
100
Registered
2024-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T300- Burn of unspecified body region, unspecified degree Health Condition 2: T200- Burn of unspecified degree of head, face, and neck Health Condition 3: T311- Burns involving 10-19% of body surface Health Condition 4: T312- Burns involving 20-29% of body surface Health Condition 5: T313- Burns involving 30-39% of body surface Health Condition 6: T314- Burns involving 40-49% of body surface Health Condition 7: T315- Burns involving 50-59% of body surface Health Condition 8:

Interventions

Intervention1: vitamine C: Patient will receive injection Vit C 1.5 gm intravenous thrice daily for 5 days. Intervention2: N-Acetyle Cysteine: Patient will receive N-Acetyl Cysteine 1gm intravenous t

Sponsors

All India Institute of Medical Sciences Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Severe burn patients in ICU

Exclusion criteria

Exclusion criteria: pregnant and lactating mothers, patients with pre-existing hepatic, respiratory, cardiac, renal failure or coagulopathy, patients previously NAC, Vit C, and MT therapy and mortality within 5days of admission

Design outcomes

Primary

MeasureTime frame
To evaluate the change in Sequential Organ Failure Assessment (SOFA) Score for 14 days after antioxidant such as Vit C, NAC, and MT adjuvant therapy in severe burn patients.Timepoint: at baseline and everyday till 7 days followed by alternate day for next 7days after initiation of intervention

Secondary

MeasureTime frame
to determine Acute Physiology and Chronic Health Evaluation (APACHE) II, Simplified Acute Physiology Score (SAPS) II, Richmond Agitation Sedation Score (RASS), C-reactive protein (CRP) and the procalcitonin (PCT) levels, incidence of delirium, vasoactive infusion score (VIS), requirement of renal replacement therapy, days of ventilatory support, ICU stay, hospital length of stay and mortality.Timepoint: at baseline and everyday till 7 days followed by alternate day for next 7days after initiation of intervention

Countries

India

Contacts

Public ContactDevishree Das

All India Institute of Medical Sciences

devishreedas111@gmail.com8895299296

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026